Self-administration of epoetin beta by peritoneal dialysis patients.

S. York, R. Kinney, Tim Taber

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Recombinant human erythropoietin (epoetin) reverses the anemia of end stage renal disease. Benefits have been evaluated primarily in hemodialysis patients because of the ease of administration via existing intravenous access. Studies are under way to evaluate the feasibility of subcutaneous self-administration of epoetin in continuous ambulatory peritoneal dialysis (CAPD) patients. Preliminary study results, using the maintenance of target hemoglobin levels to measure success and a case study demonstrate the practicality of subcutaneous self-administration of epoetin in CAPD patients.

Original languageEnglish
Pages (from-to)549-552
Number of pages4
JournalANNA journal / American Nephrology Nurses" Association
Volume18
Issue number6
StatePublished - Dec 1991
Externally publishedYes

Fingerprint

Self Administration
Peritoneal Dialysis
Continuous Ambulatory Peritoneal Dialysis
Erythropoietin
Chronic Kidney Failure
Renal Dialysis
Anemia
Hemoglobins
Maintenance
epoetin beta

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Self-administration of epoetin beta by peritoneal dialysis patients. / York, S.; Kinney, R.; Taber, Tim.

In: ANNA journal / American Nephrology Nurses" Association, Vol. 18, No. 6, 12.1991, p. 549-552.

Research output: Contribution to journalArticle

@article{2efd42c5fac440f382ed09cf15f1a898,
title = "Self-administration of epoetin beta by peritoneal dialysis patients.",
abstract = "Recombinant human erythropoietin (epoetin) reverses the anemia of end stage renal disease. Benefits have been evaluated primarily in hemodialysis patients because of the ease of administration via existing intravenous access. Studies are under way to evaluate the feasibility of subcutaneous self-administration of epoetin in continuous ambulatory peritoneal dialysis (CAPD) patients. Preliminary study results, using the maintenance of target hemoglobin levels to measure success and a case study demonstrate the practicality of subcutaneous self-administration of epoetin in CAPD patients.",
author = "S. York and R. Kinney and Tim Taber",
year = "1991",
month = "12",
language = "English",
volume = "18",
pages = "549--552",
journal = "Nephrology Nursing Journal",
issn = "1526-744X",
publisher = "Jannetti Publications, Inc.",
number = "6",

}

TY - JOUR

T1 - Self-administration of epoetin beta by peritoneal dialysis patients.

AU - York, S.

AU - Kinney, R.

AU - Taber, Tim

PY - 1991/12

Y1 - 1991/12

N2 - Recombinant human erythropoietin (epoetin) reverses the anemia of end stage renal disease. Benefits have been evaluated primarily in hemodialysis patients because of the ease of administration via existing intravenous access. Studies are under way to evaluate the feasibility of subcutaneous self-administration of epoetin in continuous ambulatory peritoneal dialysis (CAPD) patients. Preliminary study results, using the maintenance of target hemoglobin levels to measure success and a case study demonstrate the practicality of subcutaneous self-administration of epoetin in CAPD patients.

AB - Recombinant human erythropoietin (epoetin) reverses the anemia of end stage renal disease. Benefits have been evaluated primarily in hemodialysis patients because of the ease of administration via existing intravenous access. Studies are under way to evaluate the feasibility of subcutaneous self-administration of epoetin in continuous ambulatory peritoneal dialysis (CAPD) patients. Preliminary study results, using the maintenance of target hemoglobin levels to measure success and a case study demonstrate the practicality of subcutaneous self-administration of epoetin in CAPD patients.

UR - http://www.scopus.com/inward/record.url?scp=0026285996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026285996&partnerID=8YFLogxK

M3 - Article

C2 - 1750786

AN - SCOPUS:0026285996

VL - 18

SP - 549

EP - 552

JO - Nephrology Nursing Journal

JF - Nephrology Nursing Journal

SN - 1526-744X

IS - 6

ER -